PDGFB and Hepatic fibrosis: Intravenous injection into a CBDL-induced liver fibrosis model showed a decrease in inflammation, collagen deposition in the liver, infarctions, and a decrease in protein markers for phosphorylated AKT and PDGFβ, suggesting the potential of miRNA treatment as a promising therapy.